CIRM Lays Out New Path: Funding More Buildings, More Research and Into New Territories (Personalized Medicine, Therapy Delivery)

California’s stem cell agency has for the first time laid out in some detail its view of the sweeping scope of its new charter -- approved by voters last fall and which directs the program into areas such as personalized medicine and therapy delivery over the next decade or so. 

The agency’s perspective will be discussed in public Thursday morning before…